Total Payments
$108,464
2024 Payments
$1,227
Companies
26
Transactions
321
Medicare Patients
7,675
Medicare Billing
$6.3M
Payment Breakdown by Category
Other$73,972 (68.2%)
Consulting$17,815 (16.4%)
Food & Beverage$8,585 (7.9%)
Travel$7,323 (6.8%)
Education$750.00 (0.7%)
Gifts$19.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $53,650 | 18 | 49.5% |
| Current or prospective ownership or investment interest | $18,384 | 8 | 16.9% |
| Consulting Fee | $17,815 | 14 | 16.4% |
| Food and Beverage | $8,585 | 233 | 7.9% |
| Travel and Lodging | $7,323 | 33 | 6.8% |
| Acquisitions | $1,769 | 1 | 1.6% |
| Education | $750.00 | 1 | 0.7% |
| Entertainment | $86.26 | 1 | 0.1% |
| Grant | $83.33 | 1 | 0.1% |
| Gift | $19.40 | 1 | 0.0% |
| Unspecified | $0 | 10 | 0.0% |
Payments by Type
General
$108,464
311 transactions
Ownership
$0
10 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $40,443 | 88 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $24,740 | 43 | $0 (2021) |
| US Retina LLC | $20,152 | 19 | $0 (2022) |
| Biogen, Inc. | $14,803 | 23 | $0 (2024) |
| Vertex Pharmaceuticals Incorporated | $1,207 | 3 | $0 (2021) |
| Alcon Vision LLC | $1,042 | 4 | $0 (2019) |
| Alimera Sciences, Inc. | $968.56 | 13 | $0 (2024) |
| Genentech USA, Inc. | $803.93 | 45 | $0 (2024) |
| ABBVIE INC. | $769.20 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $666.23 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,227 | 20 | Astellas Pharma US Inc ($323.05) |
| 2023 | $667.77 | 30 | Regeneron Healthcare Solutions, Inc. ($196.54) |
| 2022 | $22,964 | 48 | Biogen, Inc. ($14,706) |
| 2021 | $16,078 | 40 | US Retina LLC ($8,472) |
| 2020 | $13,878 | 50 | Allergan, Inc. ($11,277) |
| 2019 | $36,327 | 66 | Novartis Pharmaceuticals Corporation ($20,285) |
| 2018 | $6,919 | 30 | Allergan Inc. ($6,135) |
| 2017 | $10,403 | 37 | Allergan Inc. ($9,648) |
All Payment Transactions
321 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/11/2024 | Topcon Healthcare, Inc. | — | Food and Beverage | Cash or cash equivalent | $103.95 | General |
| 11/15/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $34.70 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $221.42 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/24/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $160.00 | General |
| Category: Ophthalmology | ||||||
| 09/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: EYE CARE | ||||||
| 09/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/30/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/21/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $134.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/20/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $120.89 | General |
| Category: Ophthalmology | ||||||
| 08/20/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Ophthalmology | ||||||
| 06/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/31/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: Ophthalmology | ||||||
| 04/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/02/2024 | Cardinal Health 110 LLC | — | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| 01/30/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Ophthalmology | ||||||
| 01/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/19/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Ophthalmology | ||||||
| 01/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: EYE CARE | ||||||
| 12/12/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.57 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/02/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $28.16 | General |
| 11/17/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/02/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $24.23 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,464 | 7,562 | $4.1M | $1.4M |
| 2022 | 15 | 1,837 | 6,489 | $4.5M | $1.6M |
| 2021 | 13 | 2,045 | 7,724 | $4.8M | $1.8M |
| 2020 | 15 | 2,329 | 7,346 | $4.3M | $1.6M |
Total Patients
7,675
Total Services
29,121
Medicare Billing
$6.3M
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 99 | 1,214 | $2.3M | $840,051 | 36.6% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 27 | 650 | $473,200 | $117,746 | 24.9% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 31 | 429 | $359,408 | $93,085 | 25.9% |
| 67028 | Injection of drug into eye | Office | 2023 | 195 | 823 | $334,750 | $81,960 | 24.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 12 | 2,280 | $163,088 | $64,832 | 39.8% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 336 | 513 | $168,777 | $47,158 | 27.9% |
| J3590 | Unclassified biologics | Office | 2023 | 15 | 18 | $119,400 | $40,699 | 34.1% |
| 92134 | Imaging of retina | Office | 2023 | 442 | 1,246 | $130,777 | $38,156 | 29.2% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 37 | 94 | $30,160 | $7,477 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $19,688 | $6,020 | 30.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 52 | 52 | $20,228 | $5,969 | 29.5% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 38 | 46 | $5,750 | $2,295 | 39.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 19 | 19 | $6,289 | $2,122 | 33.7% |
| 92250 | Photography of the retina | Office | 2023 | 67 | 81 | $8,424 | $1,985 | 23.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 25 | 27 | $6,291 | $1,731 | 27.5% |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 24 | $2,328 | $928.56 | 39.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 122 | 1,446 | $2.7M | $1.0M | 38.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 40 | 1,206 | $877,968 | $269,888 | 30.7% |
| 67028 | Injection of drug into eye | Office | 2022 | 224 | 1,064 | $347,850 | $104,679 | 30.1% |
| 92134 | Imaging of retina | Office | 2022 | 455 | 1,398 | $131,350 | $42,734 | 32.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 364 | 467 | $135,220 | $42,110 | 31.1% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 74 | 237 | $70,720 | $17,674 | 25.0% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2022 | 13 | 14 | $41,134 | $13,510 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 78 | 78 | $29,471 | $8,968 | 30.4% |
| 92250 | Photography of the retina | Office | 2022 | 201 | 286 | $29,744 | $7,913 | 26.6% |
About Dr. Brian Joondeph, MD
Dr. Brian Joondeph, MD is a Ophthalmology healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932151230.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Joondeph, MD has received a total of $108,464 in payments from pharmaceutical and medical device companies, with $1,227 received in 2024. These payments were reported across 321 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($53,650).
As a Medicare-enrolled provider, Joondeph has provided services to 7,675 Medicare beneficiaries, totaling 29,121 services with total Medicare billing of $6.3M. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Denver, CO
- Active Since 05/16/2006
- Last Updated 03/11/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1932151230
Products in Payments
- OZURDEX (Drug) $39,676
- BEOVU (Drug) $6,725
- Lucentis (Biological) $655.39
- EYLEA (Biological) $411.76
- EYLEA HD (Biological) $388.61
- DAILIES (Device) $343.61
- YUTIQ (Drug) $323.83
- Izervay (Drug) $323.05
- EVA Ophthalmic Surgical System (Device) $313.79
- Iluvien (Biological) $294.72
- Vabysmo (Drug) $293.75
- VABYSMO (Drug) $207.78
- Cimerli (Biological) $201.71
- ILUVIEN (Drug) $199.85
- Iluvien (Drug) $151.51
- SUSVIMO (Drug) $138.89
- P200DTx (Device) $86.26
- Jetrea (Drug) $81.67
- Spectralis (Device) $75.99
- STELLARIS PC (Device) $75.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Denver
Mr. Jerry Popham, M.d, M.D
Ophthalmology — Payments: $799,779
Ophthalmology $799,779
Jack Zamora, Md, MD
Ophthalmology — Payments: $666,046
Ophthalmology $666,046
Alan Kimura, Md, MD
Ophthalmology — Payments: $589,846
Ophthalmology $589,846
Dr. Cristos Ifantides, M.d, M.D
Ophthalmology — Payments: $143,630
Ophthalmology $143,630
Dr. Eva Kim, Md, MD
Ophthalmology — Payments: $65,451
Ophthalmology $65,451
Dr. Michael Jansen, M.d, M.D
Ophthalmology — Payments: $44,975
Ophthalmology $44,975